Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells


In this pilot study, we investigated the ability of autologous dendritic cells pulsed ex vivo with tumor–specific idiotype protein to stimulate host antitumor immunity when infused as a vaccine. Four patients with follicular B–cell lymphoma received a series of three or four infusions of antigen–pulsed dendritic cells followed, in each instance, by subcutaneous injections of soluble antigen two weeks later. All patients developed measurable antitumor cellular immune responses. In addition, clinical responses have been measured with one patient experiencing complete tumor regression, a second patient having partial tumor regression, and a third patient resolving all evidence of disease as detected by a sensitive tumor–specific molecular analysis.


  1. 1

    Lynch, R.G. et al. Immunoregulation of murine myeloma cell growth and differentiation: A monoclonal model of B cell differentiation. Immunol. Rev. 48, 45–80 (1979).

    CAS  Article  Google Scholar 

  2. 2

    Levy, R., Hatzubia, A., Brown, S., Maloney, D. & Dilley, J. Immunoglobulin idiotype: A tumor-specific antigen for human B-cell lymphomas. in Malignant Lymphomas, ch. 5 (Academic Press, New York, 1982).

    Google Scholar 

  3. 3

    Maloney, D.G., Kaminski, M.S., Burowski, D., Haimovich, J. & Levy, R. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: Characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4, 191–209 (1985).

    CAS  Article  Google Scholar 

  4. 4

    Miller, R.A., Maloney, D.G., Warnke, R. & Levy, R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N. Engl. J. Med. 306, 517–522 (1982).

    CAS  Article  Google Scholar 

  5. 5

    Maloney, D.G. et al. Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: The addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells. Blood 80, 1502–1510 (1992).

    CAS  PubMed  Google Scholar 

  6. 6

    Campbell, M.J., Esserman, L., Byars, N.E., Allison, A.C. & Levy, R. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J. Immunol. 145, 1029–1036 (1990).

    CAS  PubMed  Google Scholar 

  7. 7

    Tao, M.H. & Levy, R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362, 755758 (1993).

    Article  Google Scholar 

  8. 8

    Chen, T.T., Tao, M.H. & Levy, R. Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 153, 4775–4787 (1994).

    CAS  PubMed  Google Scholar 

  9. 9

    George, A.J., Folkard, S.G., Hamblin, T.J. & Stevenson, F.K. Idiotypic vaccination as a treatment for a B cell lymphoma. J. Immunol. 141, 2168–2174 (1988).

    CAS  PubMed  Google Scholar 

  10. 10

    Campbell, M.J., Esserman, L. & Levy, R. Immunotherapy of established murine B cell lymphoma: Combination of idiotype immunization and cyclophos-phamide. J. Immunol. 141, 3227–3233 (1988).

    CAS  PubMed  Google Scholar 

  11. 11

    Hsu, F.J. et al. Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann. NY Acad. Sci. 690, 385–387 (1993).

    CAS  Article  Google Scholar 

  12. 12

    Kwak, L.W. et al. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med. 327, 1209–1215 (1992).

    CAS  Article  Google Scholar 

  13. 13

    McCabe, B.J. et al. Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses. Cancer Res. 55, 1741–1747 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. 14

    Kantor, J. et al. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate. Cancer Res. 52, 6917–6925 (1992).

    CAS  PubMed  Google Scholar 

  15. 15

    Steinman, R.M. The dendritic cell system and its role in irnmunogenicity. Annu Rev. Immunol. 9, 271–296 (1991).

    CAS  Article  Google Scholar 

  16. 16

    Larsen, C.P. et al. Regulation of immunostimulatory function and costimula-tory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152, 5208–5219 (1994).

    CAS  PubMed  Google Scholar 

  17. 17

    Hathcock, K.S., Laszlo, G., Pucillo, C., Linsley, P. & Hodes, R.J. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J. Exp. Med. 180, 631–640 (1994).

    CAS  Article  Google Scholar 

  18. 18

    Hart, D.N.J. & McKenzie, J.L. Isolation and characterization of human tonsil dendritic cells. J. Exp. Med. 168, 157–170 (1988).

    CAS  Article  Google Scholar 

  19. 19

    Freudenthal, P.S. & Steinman, R.M. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA 87, 7698–7702 (1990).

    CAS  Article  Google Scholar 

  20. 20

    Macatonia, S.E. et al. Dendritic cells produce IL-12 and direct the development of Thl cells from naive CD4+ T cells. J. Immunol. 154, 5071–5079 (1995).

    CAS  PubMed  Google Scholar 

  21. 21

    Pure, E. et al. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp. Med. 172, 1459–1469 (1990).

    CAS  Article  Google Scholar 

  22. 22

    Inaba, K., Metlay, J.P., Crowley, M.T. & Steinman, R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172, 631–640 (1990).

    CAS  Article  Google Scholar 

  23. 23

    Mehta, D.A., Markowicz, S. & Engleman, E.G. Generation of antigen-specific CD8+ CTLs from naive precursors. J. Immunol. 153, 996–1003 (1994).

    Google Scholar 

  24. 24

    Mehta, D.A., Markowicz, S. & Engleman, E.G. Generation of antigen-specific CD4+ T cell lines from naive precursors. Ear. J. Immunol. 25, 1206–1211 (1995).

    Article  Google Scholar 

  25. 25

    Fagnoni, F.F. et al. Role of B70/B7-2 in CD4+ T cell immune responses induced by dendritic cells. Immunology 85, 467–474 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. 26

    Flamand, V. et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24, 605–610 (1994).

    CAS  Article  Google Scholar 

  27. 27

    Boog, C.J. et al. Abolition of specific immune response defect by immunization with dendritic cells. Nature 318, 59–62 (1985).

    CAS  Article  Google Scholar 

  28. 28

    Takamizawa, M., Fagnoni, F., Mehta, D.A., Rivas, A. & Engleman, E.G. Cellular and molecular basis of human gamma delta T cell activation: Role of accessory molecules in alloactivation. J. Clin. Invest. 95 296–303 (1995).

    CAS  Article  Google Scholar 

  29. 29

    Carroll, W.L., Thielemans, K., Dilley, J. & Levy, R. Mouse × human heterohy-bridomas as fusion partners with human B cell tumors. J. Immunol. Methods 89, 61–72 (1986).

    CAS  Article  Google Scholar 

  30. 30

    Koch, F. et al. Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J. Immunol. 155, 93–100 (1995).

    CAS  PubMed  Google Scholar 

  31. 31

    Nijman, H.W. et al. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 182, 163–174 (1995).

    CAS  Article  Google Scholar 

  32. 32

    Boel, P. et al. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2, 167–175 (1995).

    CAS  Article  Google Scholar 

  33. 33

    Marchand, M., Brasseur, F., van der Bruggen, P., Coulie, P., & Boon, T., Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1. Dermatology 186, 278–280 (1993).

    CAS  Article  Google Scholar 

  34. 34

    Marland, G., Bakker, A.B.H., Huijbens, R.J.F., Adema, G.J. & Figdor, C.G. Primary immune response induction by dendritic cells. J. Cell. Biol. suppl 21A, 21 (1995).

  35. 35

    Kotera, Y., Fontenot, J.D., Pecher, G., Metzgar, R.S. & Finn, O.J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res. 54, 2856–2860 (1994).

    CAS  PubMed  Google Scholar 

  36. 36

    Caux, C., Dezutter, D.C., Schmitt, D. & Banchereau, J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360, 258–261 (1992).

    CAS  Article  Google Scholar 

  37. 37

    Romani, N. et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83–93 (1994).

    CAS  Article  Google Scholar 

  38. 38

    Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179 1109–1118 (1994).

    CAS  Article  Google Scholar 

  39. 39

    Hsu, F.J. & Levy, R. Preferential use of the VH4 immunoglobulin gene family by diffuse large cell lymphoma. Blood 86, 3072–3082 (1995).

    CAS  PubMed  Google Scholar 

  40. 40

    Grabstein, K. . in Selected Methods in Cellular Immunology (eds. Mishell, B.B. & Shiigi, S.M.) 124–137 (Freeman, San Francisco, 1980).

    Google Scholar 

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hsu, F., Benike, C., Fagnoni, F. et al. Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells. Nat Med 2, 52–58 (1996).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing